Pirfenidone-induced Eosinophilic Pleurisy

Intern Med. 2017;56(14):1863-1866. doi: 10.2169/internalmedicine.56.7738. Epub 2017 Jul 15.

Abstract

The patient was a 69-year-old man with idiopathic pulmonary fibrosis who was taking pirfenidone. After 7 weeks of treatment, he suffered from left-sided eosinophilic pleurisy. Medical thoracoscopy was performed and the histopathological examination of the parietal pleura revealed the massive infiltration of eosinophils and lymphoid follicles. After stopping pirfenidone therapy, the patient's pleural effusion disappeared without additional treatment, and never recurred. This is the first case report of pirfenidone-induced pleurisy.

Keywords: drug-induced pleurisy; eosinophilic pleurisy; medical thoracoscopy; pirfenidone.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Eosinophils / metabolism*
  • Humans
  • Male
  • Pleurisy / chemically induced*
  • Pleurisy / diagnosis
  • Pulmonary Fibrosis / drug therapy*
  • Pyridones / adverse effects*
  • Pyridones / therapeutic use
  • Thoracoscopy

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Pyridones
  • pirfenidone